Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study

被引:1
|
作者
Bjornsson, Oddur [1 ]
Jonsson, Eirikur [1 ]
Gudmundsson, Eirikur Orri [1 ]
Marteinsson, Valur Thor [2 ]
Nikulasson, Sigfus Thor [3 ]
Gudjonsson, Sigurdur [1 ]
机构
[1] Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland
[2] Akureyri Hosp, Dept Surg, Akureyri, Iceland
[3] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland
关键词
Upper tract urothelial carcinoma; nephroureterectomy; bladder recurrence; survival; UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; BLADDER-TUMORS; PREVENTION; PREDICTORS; RECURRENCE; SURVIVAL; OUTCOMES; TRIAL;
D O I
10.1080/21681805.2021.1916073
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective Radical nephroureterectomy is the standard treatment of organ-confined upper tract urothelial carcinoma (UTUC). The objective of this study was to investigate survival and bladder recurrence rate in Icelandic patients with UTUC who underwent radical nephroureterctomy (RNU) or other procedures with curative intent. Material and methods All patients who were diagnosed with UTUC in Iceland from 2003 to 2016 and treated with curative intent were included in the study. Information on patients was obtained retrospectively from patients' medical records and from the Icelandic Cause of Death Registry. Results Overall 63 patients underwent a procedure for UTUC with curative intent in Iceland during the study period. The median age was 71 years and the majority were male (65%). In 50 patients (79%), the tumor was a primary UTUC. The most common procedure was RNU (78%) and eight patients (13%) underwent a kidney-sparing procedure. No patient died within 90 d of surgery. Twenty-eight patients (44%) had pathological stage T2 or higher, whereas 35 patients (56%) had pathological stage T1 or lower. The median follow-up time was 98.8 months . During the follow-up time 25 patients (40%) were diagnosed with recurrence in the bladder. Five-year cancer-specific survival (CSS) was 67%. Conclusions This population-based study shows that the oncologic outcome in Icelandic patients with UTUC is similar to what has been reported in other countries. Bladder recurrence rate is high and can hopefully be reduced by improvements in surgical and intravesical instillation treatment. Possibly more kidney-sparing surgeries could have been done during the study period; however, careful selection for those procedures is mandatory.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 50 条
  • [1] Impact of surgical management of upper tract urothelial cancer in octogenarians: A population-based study
    Wang, Shu
    Phelan, Michael
    Siddiqui, Mohummad Minhaj
    CURRENT UROLOGY, 2024, 18 (03) : 225 - 231
  • [2] Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients
    Lughezzani, Giovanni
    Jeldres, Claudio
    Isbarn, Hendrik
    Sun, Maxine
    Shariat, Shahrokh F.
    Alasker, Ahmed
    Pharand, Daniel
    Widmer, Hugues
    Arjane, Philippe
    Graefen, Markus
    Montorsi, Francesco
    Perrotte, Paul
    Karakiewicz, Pierre I.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (18) : 3291 - 3297
  • [3] Dialysis Increases the Risk of Bladder Recurrence in Patients with Upper Tract Urothelial Cancer: A Population-Based Study
    Lin, Ming-Yen
    Li, Wei-Ming
    Huang, Chun-Nung
    Lee, Huei-Lan
    Niu, Sheng-Wen
    Chen, Li-Tzong
    Wu, Wen-Jeng
    Hwang, Shang-Jyh
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) : 1086 - 1093
  • [4] A Survival Model for Patients with Upper Tract Urothelial Carcinoma
    Sun, Chengliang
    Zhou, Xuewu
    Lou, Jiangyong
    ARCHIVOS ESPANOLES DE UROLOGIA, 2023, 76 (05): : 357 - 362
  • [5] Diagnosis and Management of Upper Tract Urothelial Carcinoma
    Lucca, Ilaria
    Leow, Jeffrey J.
    Shariat, Shahrokh F.
    Chang, Steven L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 271 - +
  • [6] Prognostic factors of upper tract urothelial carcinoma
    Elalouf, V.
    Klap, J.
    Delongcharnps, N. -B.
    Conquy, S.
    Sibony, M.
    Saighi, D.
    Peyromaure, M.
    Flam, T.
    Zerbib, M.
    Xylinas, E.
    PROGRES EN UROLOGIE, 2013, 23 (16): : 1382 - 1388
  • [7] Survival after nephroureterectomy for upper tract urothelial carcinoma: A population-based competing-risks analysis
    Gandaglia, Giorgio
    Bianchi, Marco
    Quoc-Dien Trinh
    Becker, Andreas
    Larouche, Alexandre
    Abdollah, Firas
    Roghmann, Florian
    Tian, Zhe
    Shariat, Shahrokh F.
    Briganti, Alberto
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    Sun, Maxine
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (03) : 249 - 256
  • [8] Neoadjuvant Chemotherapy Improves Survival of Patients With Upper Tract Urothelial Carcinoma
    Porten, Sima
    Siefker-Radtke, Arlene O.
    Xiao, Lianchun
    Margulis, Vitaly
    Kamat, Ashish M.
    Wood, Christopher G.
    Jonasch, Eric
    Dinney, Colin P. N.
    Matin, Surena F.
    CANCER, 2014, 120 (12) : 1794 - 1799
  • [9] Perioperative management of upper tract urothelial carcinoma in the Nordic countries
    Oedorf, Kimie
    Haug, Erik Skaaheim
    Liedberg, Fredrik
    Jaervinen, Riikka
    Gudjonsson, Sigurdur
    Bostroem, Peter J.
    Jerlstroem, Tomas
    Gudbrandsdottir, Gigja
    Jensen, Jorgen Bjerggaard
    Lam, Gitte Wrist
    BMC UROLOGY, 2024, 24 (01):
  • [10] Endoscopic excision versus radical nephroureterectomy for non-muscle invasive upper tract urothelial carcinoma: A population-based large cohort study
    Ye, Yuzhong
    Zheng, Yongqiang
    Li, Junteng
    Miao, Qi
    Lin, Mei
    Chen, Jiawei
    Ruan, Hailong
    Zhang, Xiaoping
    HELIYON, 2023, 9 (12)